share_log

JonesTrading Initiates Coverage On Purple Biotech With Buy Rating, Announces Price Target of $8

JonesTrading Initiates Coverage On Purple Biotech With Buy Rating, Announces Price Target of $8

JoneStrading启动对Purple Biotech的报道,评级为买入,宣布目标股价为8美元
Benzinga ·  2023/07/21 05:13

JonesTrading analyst Catherine Novack initiates coverage on Purple Biotech (NASDAQ:PPBT) with a Buy rating and announces Price Target of $8.

JoneStrading分析师凯瑟琳·诺瓦克开始对Purple Biotech(纳斯达克股票代码:PPBT)进行报道,评级为买入,并宣布目标股价为8美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发